Commonwealth of Pennsylvania Public School Employees Retirement System’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$640K Sell
13,763
-417
-3% -$20K ﹤0.01% 1342
2026
Q1
$733K Sell
14,180
-15
-0.1% -$764 ﹤0.01% 1252
2025
Q4
$705K Sell
14,195
-85
-0.6% -$4.13K ﹤0.01% 1260
2025
Q3
$682K Sell
14,280
-95
-0.7% -$3.83K ﹤0.01% 1260
2025
Q2
$453K Buy
14,375
+1,161
+9% +$37.2K ﹤0.01% 1362
2025
Q1
$433K Buy
13,214
+1,426
+12% +$50.5K ﹤0.01% 1343
2024
Q4
$426K Buy
11,788
+9
+0.1% +$317 ﹤0.01% 1338
2024
Q3
$367K Sell
11,779
-67
-0.6% -$2.09K ﹤0.01% 1363
2024
Q2
$317K Buy
11,846
+48
+0.4% +$1.39K ﹤0.01% 1360
2024
Q1
$402K Buy
11,798
+9
+0.1% +$268 ﹤0.01% 1274
2023
Q4
$341K Sell
11,789
-24,709
-68% -$655K ﹤0.01% 1326
2023
Q3
$1.01M Sell
36,498
-25,080
-41% -$763K 0.01% 1058
2023
Q2
$1.85M Buy
61,578
+4,340
+8% +$152K 0.01% 1054
2023
Q1
$2.07M Sell
57,238
-616
-1% -$23.7K 0.02% 868
2022
Q4
$2.06M Buy
57,854
+9,114
+19% +$317K 0.02% 849
2022
Q3
$1.65M Buy
48,740
+49
+0.1% +$1.59K 0.02% 839
2022
Q2
$1.41M Buy
48,691
+2,844
+6% +$81.5K 0.02% 1016
2022
Q1
$1.48M Buy
45,847
+5,653
+14% +$173K 0.01% 1070
2021
Q4
$1.17M Sell
40,194
-102
-0.3% -$3.1K 0.01% 1189
2021
Q3
$1.07M Sell
40,296
-392
-1% -$10.5K 0.01% 1212
2021
Q2
$1.25M Sell
40,688
-126
-0.3% -$3.86K 0.01% 1124
2021
Q1
$1.07M Buy
40,814
+1
+0% +$28 0.01% 1220
2020
Q4
$1.03M Sell
40,813
-53
-0.1% -$1.14K 0.01% 1126
2020
Q3
$852K Buy
40,866
+14,419
+55% +$327K 0.02% 1045
2020
Q2
$628K Buy
26,447
+51
+0.2% +$1.13K 0.01% 949
2020
Q1
$475K Buy
26,396
+8,610
+48% +$181K 0.01% 1015
2019
Q4
$422K Sell
17,786
-4
-0% -$97 0.01% 1198
2019
Q3
$489K Sell
17,790
-151
-0.8% -$4.47K 0.01% 1039
2019
Q2
$594K Sell
17,941
-16
-0.1% -$548 0.01% 913
2019
Q1
$629K Buy
17,957
+38
+0.2% +$1.41K 0.01% 879
2018
Q4
$595K Buy
17,919
+5,454
+44% +$235K 0.01% 811
2018
Q3
$628K Buy
12,465
+1,509
+14% +$74.5K 0.01% 969
2018
Q2
$656K Buy
10,956
+6,136
+127% +$318K 0.01% 997
2018
Q1
$221K Buy
+4,820
New +$201K ﹤0.01% 1162

Other funds holding SUPN

Commonwealth of Pennsylvania Public School Employees Retirement System's SUPN Position: Q2 2026 in Review

Commonwealth of Pennsylvania Public School Employees Retirement System reduced its Supernus Pharmaceuticals (SUPN) stake by 2.9% in Q2 2026, selling an estimated $20K and leaving 13,763 shares worth $640K. The position accounts for ﹤0.01% of the portfolio, ranked #1342.

Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in SUPN in Q1 2018 and has held it in 34 quarters since. The position peaked at $2.07M in Q1 2023. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Commonwealth of Pennsylvania Public School Employees Retirement System held 13,763 shares of Supernus Pharmaceuticals worth $640K as of Q2 2026.
  • Commonwealth of Pennsylvania Public School Employees Retirement System sold 417 Supernus Pharmaceuticals shares in Q2 2026, an estimated $20K.
  • Supernus Pharmaceuticals made up ﹤0.01% of Commonwealth of Pennsylvania Public School Employees Retirement System's portfolio in Q2 2026, its #1342 holding.
  • Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in Supernus Pharmaceuticals in Q1 2018 and has held it in 34 quarters since.
  • Commonwealth of Pennsylvania Public School Employees Retirement System's Supernus Pharmaceuticals position peaked at $2.07M in Q1 2023.
  • 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Commonwealth of Pennsylvania Public School Employees Retirement System's 13F filing for Q2 2026, filed 17 Jul 2026.